Omaxe Intrinsic Value
Omaxe intrinsic value. Omaxe (OMAXE) median intrinsic value is ₹107.55 from 2 valuation models (range ₹66–₹108), vs current price ₹107.43 — +0.1% upside (Trading Near Calculated Value), margin of safety 0.1%. Read OMAXE dividend yield for the complete payout history and dividend yield track record.
OMAXE Valuation Methods Summary — DCF, Graham Number & P/E
Omaxe intrinsic value across 2 models vs current price ₹107.43 — upside/downside and value range per method. For current market price and key ratios, visit Omaxe screener.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Revenue Multiple Method | revenue | ₹65.75 | ₹59.18 - ₹72.33 | -38.8% | Revenue/Share: ₹82.19, P/S: 0.8x |
| Simple DCF (5Y) | dcf | ₹107.55 | ₹86.04 - ₹129.06 | +0.1% | CF Growth: 5.0%, Discount: 15% |
OMAXE Intrinsic Value vs Market Price — All Valuation Models
Omaxe fair value range ₹66–₹108 vs current market price ₹107.43 across 2 valuation models. Compare with Omaxe value estimation to assess whether the stock is under or overvalued.
OMAXE Intrinsic Value Analysis — Undervalued or Overvalued?
Omaxe median intrinsic value ₹107.55, current price ₹107.43 — Trading Near Calculated Value by 0.1%, margin of safety 0.1%.
What is the intrinsic value of OMAXE?
Based on our comprehensive analysis using 2 different valuation methods, the estimated intrinsic value of Omaxe (OMAXE) is ₹107.55 (median value). With the current market price of ₹107.43, this represents a +0.1% variance from our estimated fair value.
The valuation range spans from ₹65.75 to ₹107.55, indicating ₹65.75 - ₹107.55.
Is OMAXE undervalued or overvalued?
Based on our multi-method analysis, Omaxe (OMAXE) appears to be trading near calculated value by approximately 0.1%.
OMAXE Financial Health — Key Ratios vs Industry Benchmarks
Omaxe financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 8.65 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 85.6% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | -58.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.09x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
OMAXE Cash Flow Quality — Operating & Free Cash Flow
Omaxe operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹212 Cr | ₹212 Cr | Positive Free Cash Flow | 8/10 |
| March 2025 | ₹1,007 Cr | ₹944 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹987 Cr | ₹955 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹469 Cr | ₹398 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹783 Cr | ₹772 Cr | Positive Free Cash Flow | 8/10 |